D
NeuroPace, Inc. NPCE
$16.36 -$0.14-0.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 35.88% -15.13% 26.17% 15.32% 24.87%
Total Depreciation and Amortization 7.98% 7.43% 9.22% 10.27% 13.32%
Total Amortization of Deferred Charges 48.94% 1.85% -37.18% -35.53% -36.49%
Total Other Non-Cash Items -0.60% 13.61% -16.23% -6.72% -19.00%
Change in Net Operating Assets -404.93% 694.60% -65.19% -277.74% -53.24%
Cash from Operations -12.76% 46.51% 0.61% -43.58% 25.11%
Capital Expenditure 70.00% -166.67% 64.42% -21.88% -1,011.11%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -42.86% -64.29%
Cash from Investing -102.14% -105.19% -101.54% -43.45% -66.60%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -64.72% 9,731.07% -88.86% 36,975.00%
Repurchase of Common Stock -50.00% -141.67% -7,569.34% -148.65% -94.29%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -108.11% -474.85% 29,216.67% -89.68% 10,833.33%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -185.82% -2,602.60% 368.56% -123.83% 38.24%